Trial Profile
Entolimod, an Adjuvant for Vaccine Augmentation
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 02 Sep 2020
Price :
$35
*
At a glance
- Drugs Entolimod (Primary) ; Diphtheria-tetanus vaccine
- Indications Substance-related disorders
- Focus Adverse reactions
- 28 Aug 2020 Status changed from active, no longer recruiting to completed.
- 08 Jul 2019 Planned End Date changed from 1 Dec 2019 to 31 Dec 2019.
- 20 Sep 2018 Status changed from recruiting to active, no longer recruiting.